Skip Navigation

Project Publications: Boston University: Administrative Core

Superfund Research Program

Administrative Core

Project Leader: David H. Sherr
Co-Investigators: Wendy J. Heiger-Bernays, Madeleine Kangsen Scammell, David M. Ozonoff
Grant Number: P42ES007381
Funding Period: 1995-2021

Project-Specific Links

Publications

2022

  • Bozinovic G, Feng Z, Shea D, Oleksiak MF. 2022. Cardiac physiology and metabolic gene expression during late organogenesis among F. heteroclitus embryo families from crosses between pollution-sensitive and -resistant parents. BMC Ecol Evol 22(3):doi:10.1186/s12862-022-01959-1 PMID:34996355 PMCID:PMC8739662

2021

  • De Silva AO, Armitage JM, Bruton TA, Dassuncao C, Heiger-Bernays WJ, Hu XC, Karrman A, Kelly B, Ng CA, Robuck AR, Sun M, Webster TF, Sunderland EM. 2021. PFAS exposure pathways for humans and wildlife: A synthesis of current knowledge and key gaps in understanding. Environ Toxicol Chem 40(3):631-657. doi:10.1002/etc.4935 PMID:33201517 PMCID:PMC7906948
  • Hoover AG, Heiger-Bernays WJ, Ojha S, Pennell KG. 2021. Balancing incomplete COVID-19 evidence and local priorities: Risk communication and stakeholder engagement strategies for school re-opening. Rev Environ Health 36:27-37. doi:10.1515/reveh-2020-0092 PMID:33001857 PMCID:PMC7933073
  • Kenison JE, Wang Z, Yang K, Snyder M, Quintana FJ, Sherr DH. 2021. The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation. Proc Natl Acad Sci U S A 118:doi:10.1073/pnas.2012692118 PMID:33941684 PMCID:PMC8126867
  • Schlezinger JJ, Hyotylainen T, Sinjoja T, Moore Boston C, Puckett H, Oliver J, Heiger-Bernays WJ, Webster TF. 2021. Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPAR(alpha) mice fed an American diet. Toxicol Appl Pharmacol 426:115644. doi:10.1016/j.taap.2021.115644 PMID:34252412 PMCID:PMC8338894

2020

  • Walker JA, Richards S, Belghasem ME, Arinze N, Yoo SB, Tashjian JY, Whelan SA, Lee N, Kolachalama VB, Francis J, Ravid K, Sherr DH, Chitalia VC. 2020. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease. Kidney International 97:538-550. doi:10.1016/j.kint.2019.09.029 PMID:31932072

2019

  • Ash P, Dhawan U, Boudeau S, Lei S, Carlomagno Y, Knobel M, Al Mohanna L, Boomhower S, Newland MC, Sherr DH, Wolozin B. 2019. Heavy metal neurotoxicants induce ALS-linked TDP-43 pathology. Toxicol Sci 167(1):105-115. doi:10.1093/toxsci/kfy267 PMID:30371865 PMCID:PMC6317426
  • Butler L, Gallagher L, Winter MR, Fabian MP, Wesselink AK, Aschengrau A. 2019. Residential proximity to roadways and placental-associated stillbirth: a case-control study. Int J Environ Health Res 31:465-474. doi:10.1080/09603123.2019.1673882 PMID:31587563 PMCID:PMC7131873
  • Li A, Lu X, Natoli T, Bittker J, Sipes N, Subramanian A, Auerbach SS, Sherr DH, Monti S. 2019. The Carcinogenome Project: in vitro gene expression profiling of chemical perturbations to predict long-term carcinogenicity. Environ Health Perspect 127:47002. doi:10.1289/EHP3986 PMID:30964323 PMCID:PMC6785232
  • Mohamed HT, Gadalla R, El-Husseiny N, Hassan H, Wang Z, Ibrahim SA, El-Shinawi M, Sherr DH, Mohamed M. 2019. Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-beta-catenin signalling, the stem cell phenotype and disease progression. J. Adv. Res 16:75-86. doi:10.1016/j.jare.2018.11.006 PMID:30899591 PMCID:PMC6413307
  • Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao C, Gutierrez-Vazquez C, Kenison JE, Tjon EC, Barroso A, Vandeventer T, Alves de Lima K, Rothweiler S, Mayo L, Ghannam S, Zandee S, Healy L, Sherr DH, Farez M, Pratt A, Antel J, Reardon DA, Zhang H, Robson SC, Getz G, Weiner HL, Quintana FJ. 2019. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci 22:729-740. doi:10.1038/s41593-019-0370-y PMID:30962630

2018

  • Esser C, Lawrence BP, Sherr DH, Perdew GH, Puga A, Barouki R, Coumoul X. 2018. Old receptor, new tricks the ever-expanding universe of aryl hydrocarbon receptor functions. Report from the 4th AHR Meeting, 29 31 August 2018 in Paris, France. Int J Mol Sci 19(11):3603. doi:10.3390/ijms19113603 PMID:30445691

2017

2016

  • Shivanna S, Kolandaivelu K, Shashar M, Belghasim M, Al-Rabadi L, Balcells M, Zhang A, Weinberg JM, Francis J, Pollastri MP, Edelman ER, Sherr DH, Chitalia VC. 2016. The aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia. J Am Soc Nephrol 27(1):189-201. doi:10.1681/ASN.2014121241 PMID:26019318 PMCID:PMC4696580
  • Smith BW, Stanford EA, Sherr DH, Murphy GJ. 2016. Genome editing of the CYP1A1 locus in iPSCs as a platform to map AHR expression throughout human development. Stem Cells Int 2016:2574152. doi:10.1155/2016/2574152 PMID:27148368 PMCID:PMC4842384
  • Stanford EA, Ramirez-Cardenas A, Wang Z, Novikov O, Alamoud K, Koutrakis P, Mizgerd JP, Genco CA, Kukuruzinska M, Monti S, Bais MV, Sherr DH. 2016. Role for the aryl hydrocarbon receptor and diverse ligands in oral squamous cell carcinoma migration and tumorigenesis. Mol Cancer Res 14(8):696-706. doi:10.1158/1541-7786.MCR-16-0069 PMID:27130942 PMCID:PMC4987205
  • Stanford EA, Wang Z, Novikov O, Ramirez-Cardenas A, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Bais MV, Kukuruzinska M, Murphy GJ, Sherr DH. 2016. A role for the aryl hydrocarbon receptor (Ahr) in the production and function of breast and oral cancer stem-like cells and the potential therapeutic value of Ahr modulators. Toxicol Lett 259:S20. doi:10.1016/j.toxlet.2016.07.090

2014

  • Parks A, Pollastri MP, Hahn ME, Stanford EA, Novikov O, Franks DG, Haigh SE, Narasimhan S, Ashton TD, Hopper TG, Kozakov D, Beglov D, Vajda S, Schlezinger JJ, Sherr DH. 2014. In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo. Mol Pharmacol 86(5):593-608. doi:10.1124/mol.114.093369 PMID:25159092 PMCID:PMC4201140

2002

  • Hoyer AP, Gerdes AM, Jorgensen T, Rank F, Hartvig HB. 2002. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat 71(1):59-65. PMID:11859874
Back
to Top